TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Abbisko Cayman Limited ( (HK:2256) ) is now available.
Abbisko Cayman Limited announced that Mr. Sun Hongbin, an independent non-executive director of the company, has been publicly criticized by the Hong Kong Stock Exchange for his conduct during his tenure at New Century Healthcare. The criticism pertains to his failure to ensure adequate steps were taken to collect receivables and safeguard interests at New Century Healthcare. Despite this, Abbisko’s board has assessed the situation and believes it will not adversely impact the company’s operations or business.
The most recent analyst rating on (HK:2256) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on Abbisko Cayman Limited stock, see the HK:2256 Stock Forecast page.
More about Abbisko Cayman Limited
Average Trading Volume: 5,612,741
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.07B
For a thorough assessment of 2256 stock, go to TipRanks’ Stock Analysis page.